Periorbital dark circles. Chloasma of eyelid and periocular area
Conditions
Interventions
Intervention 1: Intervention group: patients are treated with Q-switched Nd:YAG 1064nm laser, 0.5 cc conditioned medium injection and 0.5cc PRP injection three times with four weeks interval. Interven
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age from 18 to 65 years Patient with periorbital dark circles
Exclusion criteria
Exclusion criteria: Active infection on face Pregnancy Breastfeeding History of cancer Structural dark circles or under eye loss of fat
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Periorbital dark circles. Timepoint: Before and 3 months after treatment. Method of measurement: severity of under eye dark halos in comparison to the rest of the face, using mexameter device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction rate. Timepoint: Three months after the last meeting. Method of measurement: comparing the severity of periorbital dark circles, before and after treatment (score from 0 - 10). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed